| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 46.905 | 69.984 | 99.273 | 15.345 | 24.280 | 37.773 | 44.257 | 81.052 |
| Total Income - EUR | - | - | 46.912 | 69.997 | 99.325 | 15.374 | 24.280 | 37.773 | 44.259 | 81.083 |
| Total Expenses - EUR | - | - | 2.855 | 13.105 | 24.093 | 17.661 | 18.820 | 19.369 | 32.938 | 33.202 |
| Gross Profit/Loss - EUR | - | - | 44.056 | 56.892 | 75.232 | -2.287 | 5.460 | 18.405 | 11.321 | 47.881 |
| Net Profit/Loss - EUR | - | - | 42.649 | 54.793 | 72.254 | -2.727 | 4.746 | 17.294 | 8.351 | 39.276 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Stoica Robert Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 2 | 1.776 | 2.114 | 464 | 65.291 | 111.295 | 107.998 | 155.038 |
| Current Assets | - | - | 45.280 | 98.323 | 174.337 | 174.322 | 112.373 | 75.521 | 101.249 | 95.562 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 9.760 | 1.025 | 246 | 3.040 | 242 | 1.389 | 13.960 |
| Cash | - | - | 45.280 | 88.563 | 173.312 | 174.076 | 109.334 | 75.279 | 99.860 | 81.602 |
| Shareholders Funds | - | - | 42.693 | 96.702 | 167.083 | 161.189 | 162.360 | 167.351 | 175.195 | 213.491 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 2.589 | 3.396 | 10.696 | 13.597 | 17.789 | 23.284 | 37.860 | 40.896 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Stoica Robert Med Srl